Chas P. Smith & Associates (CPS)’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $572K | Sell |
|
|||||
|
2025
Q1 | $1.11M | Sell |
|
|||||
|
2024
Q4 | $1.24M | Sell |
|
|||||
|
2024
Q3 | $1.69M | Sell |
|
|||||
|
2024
Q2 | $1.88M | Sell |
|
|||||
|
2024
Q1 | $2.17M | Sell |
|
|||||
|
2023
Q4 | $2.6M | Sell |
|
|||||
|
2023
Q3 | $3.63M | Sell |
|
|||||
|
2023
Q2 | $4.9M | Sell |
|
|||||
|
2023
Q1 | $29.7M | Buy |
|
|||||
|
2022
Q4 | $36.9M | Buy |
|
|||||
|
2022
Q3 | $31.3M | Buy |
|
|||||
|
2022
Q2 | $37.3M | Buy |
|
|||||
|
2022
Q1 | $36.5M | Sell |
|
|||||
|
2021
Q4 | $41.7M | Sell |
|
|||||
|
2021
Q3 | $30.7M | Buy |
|
|||||
|
2021
Q2 | $27.3M | Buy |
|
|||||
|
2021
Q1 | $24.6M | Buy |
|
|||||
|
2020
Q4 | $23.9M | Sell |
|
|||||
|
2020
Q3 | $23.3M | Sell |
|
|||||
|
2020
Q2 | $20.9M | Sell |
|
|||||
|
2020
Q1 | $21M | Buy |
|
|||||
|
2019
Q4 | $24.6M | Buy |
|
|||||
|
2019
Q3 | $22.5M | Sell |
|
|||||
|
2019
Q2 | $27.2M | Sell |
|
|||||
|
2019
Q1 | $27.4M | Sell |
|
|||||
|
2018
Q4 | $28.7M | Sell |
|
|||||
|
2018
Q3 | $29.9M | Sell |
|
|||||
|
2018
Q2 | $24.9M | Buy |
|
|||||
|
2018
Q1 | $24M | Buy |
|
|||||
|
2017
Q4 | $24M | Buy |
|
|||||
|
2017
Q3 | $23.1M | Sell |
|
|||||
|
2017
Q2 | $22M | Buy |
|
|||||
|
2017
Q1 | $22.2M | Buy |
|
|||||
|
2016
Q4 | $19.1M | Sell |
|
|||||
|
2016
Q3 | $39M | Buy |
|
|||||
|
2016
Q2 | $20.2M | Buy |
|
|||||
|
2016
Q1 | $17M | Sell |
|
|||||
|
2015
Q4 | $18.6M | Buy |
|
|||||
|
2015
Q3 | $18.1M | Sell |
|
|||||
|
2015
Q2 | $19.6M | Buy |
|
|||||
|
2015
Q1 | $20.1M | Buy |
|
|||||
|
2014
Q4 | $17.8M | Buy |
|
|||||
|
2014
Q3 | $16.5M | Buy |
|
|||||
|
2014
Q2 | $15.6M | Sell |
|
|||||
|
2014
Q1 | $49.3M | Buy |
|
|||||
|
2013
Q4 | $46.1M | Buy |
|
|||||
|
2013
Q3 | $14.2M | Buy |
|
|||||
|
2013
Q2 | $13.4M | Buy |
|